Clinical study of transjugular intrahepatic portosystemic shunt for cirrhosis with portal hypertension
ZHAO Yulong LIU Shunshun YAO Dejiong LIANG Weijun HUANG Hui WANG Zhongwei
Ward Two, General Surgery Department, the First Division Hospital of Xinjiang Production and Construction Corps, Xinjiang Uygur Autonomous Region, Akesu 843000, China
Abstract:Objective To investigate the efficacy of transjugular intrahepatic portosystemic shunt for cirrhosis with portal hypertension. Methods Fifty-four cases of cirrhosis patients with portal hypertension admitted to the First Division Hospital of Xinjiang Production and Construction Corps from January 2015 to December 2016 were selected. According to random number table method, they were divided into observation group and control group, with 27 cases in each group. The observation group was treated by transjugular intrahepatic portosystemic shunt, and the control group was treated by pericardial devascularization. The operation effect, hemodynamic indexes and liver function indexes before and after operation of two groups were compared, and the incidence of adverse events after operation was observed. Results There was no significant difference in total clinical effective rate between the two groups (P > 0.05). After operation, the diameter of portal vein, portal vein blood flow, splenic vein diameter and splenic vein blood flow in observation group were lower than those of control group, while the portal venous flow velocity and the splenic vein velocity were higher than those of control group, the differences were statistically significant (P < 0.05). After operation, the levels of alanine transaminase, aspartate aminotransferase and total bilirubin in observation group were lower than those of control group (P < 0.05). The incidence of adverse events in observation group was significantly lower than that in control group (P < 0.05). Conclusion Transjugular intrahepatic portosystemic shunt is effective in the treatment of cirrhosis with portal hypertension. It can significantly improve the hemodynamic indexes and liver function, and reduce the incidence of postoperative adverse events.